Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Sep;85(3):373–378. doi: 10.1111/j.1365-2249.1991.tb05734.x

Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).

N Madi 1, G Steiger 1, J Estreicher 1, J A Schifferli 1
PMCID: PMC1535628  PMID: 1893616

Abstract

Complement levels and complement receptor 1 (CR1) on erythrocytes (E) are reduced in systemic lupus erythematosus (SLE). To see whether these abnormalities are responsible for defective transport and elimination of immune complexes (IC) from the circulation, patients with active SLE (14) and normal volunteers (14) were injected with preformed IC (hepatitis B surface Ag/Ab). Two minutes after injection only 25.9 +/- 19.1% (mean +/- 1 s.d.) of the circulating IC were bound to E in the SLE patients as compared to 63 +/- 3.7% in the normal subjects (P = 0.0001). For SLE patients, the reduced immune adherence was best explained by a combination of complement depletion and low CR1 binding capacity (tau = 0.80, P = 0.0001). The disappearance of IC as estimated from the area under the elimination curve was faster in SLE than in controls (P = 0.02), and correlated with CR1 (tau = 0.54, P = 0.0001) and immune adherence observed in vivo (tau = 0.33, P = 0.013). Finally, immune adherence was absent and IC disappeared very rapidly in a patient with C2 deficiency and an SLE-like disease. These observations suggest that in SLE the defective immune adherence reaction might be responsible for the accelerated disappearance of IC from the circulation.

Full text

PDF
373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron J. S., Clark W. F. A role for insoluble antibody-antigen complexes in glomerulonephritis? Clin Nephrol. 1982 Aug;18(2):55–61. [PubMed] [Google Scholar]
  2. Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxman F. J. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983 Feb;71(2):236–247. doi: 10.1172/JCI110764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Daha M. R., Van Es L. A. Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages. Immunology. 1983 Sep;50(1):107–111. [PMC free article] [PubMed] [Google Scholar]
  4. Edberg J. C., Kujala G. A., Taylor R. P. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation. J Immunol. 1987 Aug 15;139(4):1240–1244. [PubMed] [Google Scholar]
  5. Edberg J. C., Tosic L., Wright E. L., Sutherland W. M., Taylor R. P. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes. J Immunol. 1988 Dec 15;141(12):4258–4265. [PubMed] [Google Scholar]
  6. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  7. Frank M. M., Lawley T. J., Hamburger M. I., Brown E. J. NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med. 1983 Feb;98(2):206–218. doi: 10.7326/0003-4819-98-2-218. [DOI] [PubMed] [Google Scholar]
  8. Halma C., Daha M. R., van Furth R., Camps J. A., Evers-Schouten J. H., Pauwels E. K., Lobatto S., Van Es L. A. Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy. Clin Exp Immunol. 1989 Jul;77(1):62–66. [PMC free article] [PubMed] [Google Scholar]
  9. Hong K., Takata Y., Sayama K., Kozono H., Takeda J., Nakano Y., Kinoshita T., Inoue K. Inhibition of immune precipitation by complement. J Immunol. 1984 Sep;133(3):1464–1470. [PubMed] [Google Scholar]
  10. Kimberly R. P., Edberg J. C., Merriam L. T., Clarkson S. B., Unkeless J. C., Taylor R. P. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest. 1989 Sep;84(3):962–970. doi: 10.1172/JCI114259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kimberly R. P., Meryhew N. L., Runquist O. A. Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction. J Immunol. 1986 Jul 1;137(1):91–96. [PubMed] [Google Scholar]
  12. Lobatto S., Daha M. R., Breedveld F. C., Pauwels E. K., Evers-Schouten J. H., Voetman A. A., Cats A., Van Es L. A. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus. Clin Exp Immunol. 1988 Apr;72(1):55–59. [PMC free article] [PubMed] [Google Scholar]
  13. Lobatto S., Daha M. R., Voetman A. A., Evers-Schouten J. H., Van Es A. A., Pauwels E. K., Van Es L. A. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol. 1987 Jul;69(1):133–141. [PMC free article] [PubMed] [Google Scholar]
  14. Lockwood C. M., Worlledge S., Nicholas A., Cotton C., Peters D. K. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med. 1979 Mar 8;300(10):524–530. doi: 10.1056/NEJM197903083001003. [DOI] [PubMed] [Google Scholar]
  15. Madi N., Paccaud J. P., Steiger G., Schifferli J. A. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans. Clin Exp Immunol. 1989 Nov;78(2):201–206. [PMC free article] [PubMed] [Google Scholar]
  16. Medof M. E., Iida K., Mold C., Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med. 1982 Dec 1;156(6):1739–1754. doi: 10.1084/jem.156.6.1739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miyakawa Y., Yamada A., Kosaka K., Tsuda F., Kosugi E., Mayumi M. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet. 1981 Sep 5;2(8245):493–497. doi: 10.1016/s0140-6736(81)90882-5. [DOI] [PubMed] [Google Scholar]
  18. Naama J. K., Mitchell W. S., Zoma A., Veitch J., Whaley K. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. Clin Exp Immunol. 1983 Feb;51(2):292–298. [PMC free article] [PubMed] [Google Scholar]
  19. Ng Y. C., Peters D. K., Cederholm-Williams S. A., Walport M. J. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1). Clin Exp Immunol. 1987 Jul;69(1):89–97. [PMC free article] [PubMed] [Google Scholar]
  20. Paccaud J. P., Steiger G., Schifferli J. A. Reduced immune adherence of antigen/antibody complexes formed in the presence of complement in vivo and in vitro. Complement Inflamm. 1989;6(6):470–479. doi: 10.1159/000463116. [DOI] [PubMed] [Google Scholar]
  21. Paccaud J. P., Steiger G., Sjöholm A. G., Spaeth P. J., Schifferli J. A. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans. Clin Exp Immunol. 1987 Aug;69(2):468–476. [PMC free article] [PubMed] [Google Scholar]
  22. Ross G. D., Yount W. J., Walport M. J., Winfield J. B., Parker C. J., Fuller C. R., Taylor R. P., Myones B. L., Lachmann P. J. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol. 1985 Sep;135(3):2005–2014. [PubMed] [Google Scholar]
  23. Schifferli J. A., Ng Y. C., Estreicher J., Walport M. J. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol. 1988 Feb 1;140(3):899–904. [PubMed] [Google Scholar]
  24. Schifferli J. A., Ng Y. C., Paccaud J. P., Walport M. J. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol. 1989 Mar;75(3):329–335. [PMC free article] [PubMed] [Google Scholar]
  25. Schifferli J. A., Pascual M., Steiger G., Schapira M., Ryser J. E., Estreicher J., Dash A. Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement. Clin Exp Immunol. 1987 Jul;69(1):188–197. [PMC free article] [PubMed] [Google Scholar]
  26. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  27. Taylor R. P., Wright E. L., Pocanic F. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes. J Immunol. 1989 Dec 1;143(11):3626–3631. [PubMed] [Google Scholar]
  28. Waldo F. B., Forristal J., Beischel L., West C. D. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus. J Clin Invest. 1985 Jun;75(6):1786–1795. doi: 10.1172/JCI111891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Waxman F. J., Hebert L. A., Cornacoff J. B., VanAman M. E., Smead W. L., Kraut E. H., Birmingham D. J., Taguiam J. M. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest. 1984 Oct;74(4):1329–1340. doi: 10.1172/JCI111543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Waxman F. J., Hebert L. A., Cosio F. G., Smead W. L., VanAman M. E., Taguiam J. M., Birmingham D. J. Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest. 1986 Jan;77(1):82–89. doi: 10.1172/JCI112306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wener M. H., Mannik M. Mechanisms of immune deposit formation in renal glomeruli. Springer Semin Immunopathol. 1986;9(2-3):219–235. doi: 10.1007/BF02099023. [DOI] [PubMed] [Google Scholar]
  32. Wilson J. G., Wong W. W., Schur P. H., Fearon D. T. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med. 1982 Oct 14;307(16):981–986. doi: 10.1056/NEJM198210143071604. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES